Filippo G Giancotti Selected Research

Filippo G Giancotti Research Topics

Disease

29	Neoplasms (Cancer) 05/2022 - 10/2004
14	Carcinogenesis 05/2022 - 08/2006
7	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2004
7	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2021 - 05/2007
5	Breast Neoplasms (Breast Cancer) 06/2016 - 08/2006
4	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 02/2013
4	Neurilemmoma (Schwannoma) 01/2021 - 02/2010
3	Acoustic Neuroma (Acoustic Neurinoma) 01/2021 - 08/2010
2	Malignant Mesothelioma 01/2017 - 08/2009
2	Carcinoma (Carcinomatosis) 02/2010 - 08/2006
2	Pathologic Neovascularization 10/2007 - 11/2004
1	Lung Neoplasms (Lung Cancer) 05/2022
1	Meningioma (Meningiomas) 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2016
1	Triple Negative Breast Neoplasms 01/2015
1	Necrosis 09/2010
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 09/2010
1	Mesothelioma 08/2009
1	Retinal Neovascularization 11/2004
1	Hypoxia (Hypoxemia) 11/2004
1	Inflammation (Inflammations) 08/2002

Drug/Important Bio-Agent (IBA)

13	IntegrinsIBA 01/2019 - 08/2002
11	Neurofibromin 2 (Merlin)IBA 01/2017 - 10/2005
5	Phosphotransferases (Kinase)IBA 05/2022 - 10/2004
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2010
4	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2017 - 02/2010
3	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 08/2009
3	tyrosine receptor (receptor, tyrosine)IBA 02/2013 - 10/2004
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2010 - 08/2006
2	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 12/2021
2	Pharmaceutical PreparationsIBA 12/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 08/2009
2	Everolimus FDA Link 01/2021 - 01/2014
2	EnzymesIBA 01/2021 - 01/2017
2	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2019 - 01/2015
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 08/2002
2	Biological ProductsIBA 01/2014 - 01/2007
2	LigandsIBA 08/2012 - 02/2010
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2011 - 02/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2011 - 02/2010
2	Focal Adhesion Protein-Tyrosine KinasesIBA 09/2010 - 02/2009
2	Integrin beta4IBA 10/2007 - 11/2004
1	Semaphorins (Semaphorin)IBA 05/2022
1	enzalutamideIBA 01/2022
1	NeuregulinsIBA 01/2022
1	AndrogensIBA 01/2019
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2018
1	myocardinIBA 01/2018
1	Long-Acting Thyroid Stimulator (LATS)IBA 01/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	pevonedistatIBA 01/2017
1	1- (4- ((2- (2- aminopyrimidin- 5- yl)- 7- methyl- 4- morpholinothieno(3,2- d)pyrimidin- 6- yl)methyl)piperazin- 1- yl)- 2- hydroxypropan- 1- oneIBA 01/2017
1	CollagenIBA 06/2016
1	TetraspaninsIBA 06/2016
1	MicroRNAs (MicroRNA)IBA 11/2014
1	TOR Serine-Threonine KinasesIBA 01/2014
1	KalininIBA 02/2013
1	Complementary DNA (cDNA)IBA 08/2012
1	ezrinIBA 08/2011
1	moesinIBA 08/2011
1	radixinIBA 08/2011
1	ElementsIBA 02/2011
1	Dasatinib (BMS 354825)FDA Link 09/2010
1	Imatinib Mesylate (Gleevec)FDA Link 09/2010
1	src-Family KinasesIBA 09/2010
1	Lapatinib (GW572016)FDA Link 08/2010
1	Bovine Serum AlbuminIBA 02/2010
1	SU 1498IBA 02/2010
1	Integrin alpha6IBA 02/2010
1	Ringer's SolutionIBA 02/2010
1	Sirolimus (Rapamycin)FDA Link 08/2009
1	p21-Activated KinasesIBA 08/2009
1	Messenger RNA (mRNA)IBA 02/2009
1	Oncogene Proteins (Oncogene Protein)IBA 02/2009
1	Laminin ReceptorsIBA 10/2007
1	Integrin alpha6beta4IBA 01/2007
1	matrigelIBA 11/2004
1	NF-kappa B (NF-kB)IBA 08/2002

Therapy/Procedure

12	Therapeutics 01/2022 - 11/2004
3	Castration 01/2022 - 02/2013
1	Transplantation 12/2019